200P-500 fetal bovine serum - lot # 204064

Ended Awarded

Contract number
HHSN267NUW33245
Awardee
Awarding agency
Obligated
$12,360

Award facts

Contract value
  • $12,360.00 Current, with exercised options
  • $0.00 Potential, with all options
Completion date
  • Current, with exercised options
  • Not on record Potential, with all options
Funding agency
Office of the Director National Institutes of Health, Department of Health and Human Services
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
0 offers Simplified Acquisition
Pricing
Other

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Modification $12,360
Other Administrative Action 1 $0

Quick answers

Who was awarded contract HHSN267NUW33245?

HHSN267NUW33245 was awarded to Biosource International Incorporated by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on September 14, 2005.

How much is contract HHSN267NUW33245 worth?

The government has obligated $12,360 on HHSN267NUW33245.

Which agency awarded contract HHSN267NUW33245?

National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) awarded HHSN267NUW33245, with funding from Office of the Director (National Institutes of Health).

Is contract HHSN267NUW33245 an order under another contract?

Yes. HHSN267NUW33245 is a BPA call under HHSN263200500062483B, a blanket purchase agreement.

Was contract HHSN267NUW33245 competed?

The government received 0 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award